Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shanmuga Hospital Limited has informed the stock exchanges about an upcoming investor and analyst meeting scheduled for 5th December 2025 in Mumbai. The meeting will be conducted physically in one-on-one and group formats, with participation from Electrum PMS, Aum Capitals, various Family Offices, HNIs, and a group of analysts organised by NUVAMA. The company has clarified that no Unpublished Price Sensitive Information (UPSI) will be shared during these interactions. This is a routine regulatory disclosure under SEBI Listing Obligations and the schedule is subject to change due to unforeseen circumstances.
This is a standard compliance filing and does not indicate any material business development. The company's explicit confirmation that no UPSI will be shared suggests no immediate catalyst is expected from the meeting. Shareholders should treat this as routine investor engagement activity with no direct impact on the stock price.